Patients with Spontaneously Ruptured Hepatocellular Carcinoma Benefit from Staged Surgical Resection after Successful Transarterial Embolization

  • Zhang, Dong-Zhi (Emergency Department, Gansu Provincial Hospital) ;
  • Zhang, Ke (Emergency Department, Gansu Provincial Hospital) ;
  • Wang, Xiao-Peng (Department of General Surgery, Gansu Provincial Hospital) ;
  • Cai, Hui (The Medical Department, Gansu Provincial Hospital)
  • Published : 2015.02.04


Background: Surgical resection of spontaneously ruptured hepatocellular carcinoma (HCC) after successful transarterial embolization (TAE) remains controversial. The aim of this study was to investigate its efficacy in a series of cases. Materials and Methods: We retrospectively examined ruptured HCC cases from Jan 2000 to Dec 2008; all of these 126 cases received TAE as the initial therapy. Subsequently, 74 cases received staged surgical resection, and the remaining 52 cases underwent repeated TACE. The baseline demographic data, tumor characteristics, and long term survival were recorded and compared. Results: The demographic and baseline characteristics were comparable between the hepatic resection and TACE groups; furthermore, no significant difference in the tumor characteristics was detected between the two groups. The differences in in-hospital, 30-day and 90-day mortality between the two groups were not significant (P>0.05). However, the 1-, 3-, and 5-year overall survival rates were 85.1%, 63.5%, and 37.8%, respectively, in the hepatic resection group, which were significantly higher than those in the TACE group (69.2%, 46.2%, and 17.3%, respectively, P=0.004). Univariate and multivariate analyses indicated that these patients benefitted from hepatic resection compared with TACE with respect to long-term outcomes. Conclusions: Staged hepatic resection after TAE is an effective treatment that results in superior long-term survival to repeated TACE.


  1. Battula N, Madanur M, Priest O, et al (2009). Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg, 197, 164-7.
  2. Bruix J, Gores GJ, Mazzaferro V (2014). Hepatocellular carcinoma: clinical frontiers and perspectives. Gut, 63, 844-55.
  3. Castells L, Moreiras M, Quiroga S, et al (2001). Hemoperitoneum as a first manifestation of hepatocellular carcinoma in western patients with liver cirrhosis: effectiveness of emergency treatment with transcatheter arterial embolization. Dig Dis Sci, 46, 555-62.
  4. Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52.
  5. Gores GJ (2014). Decade in review-hepatocellular carcinoma: HCC-subtypes, stratification and sorafenib. Nat Rev Gastroenterol Hepatol, 11, 645-7.
  6. Huang Z, Zhang P, Wang H, et al (2014). Comparing outcomes of two vascular inflow occlusion techniques and treatment without vascular occlusion during major hepatectomy in patients with Hepatitis B-related hepatocellular carcinoma. PLoS One, 9, 107303.
  7. Jemal A, Bray F, Center MM, et al(2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  8. Jin YJ, Lee JW, Park SW, et al (2013). Survival outcome of patients with spontaneously ruptured hepatocellular carcinoma treated surgically or by transarterial embolization. World J Gastroenterol, 19, 4537-44.
  9. Jianyong L, Jinjing Z, Wentao W, et al (2014). Preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: a single center analysis. Ann Hepatol, 13, 394-402.
  10. Kirikoshi H, Saito S, Yoneda M, et al (2009). Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study. BMC Gastroenterol, 9, 29.
  11. Lei J, Wang W, Yan L (2013). Surgical resection versus openapproach radiofrequency ablation for small hepatocellular carcinomas within Milan criteria after successful transcatheter arterial chemoembolization. J Gastrointest Surg, 17, 1752-9.
  12. Li WH, Cheuk EC, Kowk PC, et al (2009). Survival after transarterial embolization for spontaneous ruptured hepatocellular carcinoma. J Hepatobiliary Pancreat Surg, 16, 508-12.
  13. Liang T, Chen EQ, Tang H (2013). Hepatitis B virus gene mutations and hepatocarcinogenesis. Asian Pac J Cancer Prev, 14, 4509-13.
  14. Miyoshi A, Kitahara K, Kohya N, et al (2011). Outcomes of patients with spontaneous rupture of hepatocellular carcinoma. Hepatogastroenterology, 58, 99-102.
  15. Shimada R, Imamura H, Makuuchi M, et al (1998). Staged hepatectomy after emergency transcatheter arterial embolization for ruptured hepatocellular carcinoma. Surgery, 124, 526-35.
  16. Shin BS, Park MH, Jeon GS (2011). Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization. Acta Radiol, 52, 331-5.
  17. Shuto T, Hirohashi K, Kubo S, et al (1998). Delayed hepatic resection for ruptured hepatocellular carcinoma. Surgery, 124, 33-7.
  18. Toshikuni N, Takuma Y, Morimoto Y, et al (2011). Transarterial embolization for ruptured hepatocellular carcinoma: survival predictors. Hepatogastroenterology, 58, 565-9.
  19. Zhu LX, Meng XL, Fan ST (2004). Elasticity of small artery in patient with spontaneous rupture of hepatocellular carcinoma. Hepatol Res, 29, 13-7.
  20. Zhu Q, Li J, Yan JJ, et al (2012). Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma. World J Gastroenterol, 18, 7302-7.

Cited by

  1. Surgical Outcomes for the Ruptured Hepatocellular Carcinoma: Multicenter Analysis with a Case-Controlled Study vol.20, pp.12, 2016,
  2. Treatment outcomes of spontaneous rupture of hepatocellular carcinoma with hemorrhagic shock: a multicenter study vol.5, pp.1, 2016,
  3. Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review pp.00224790, 2017,
  4. Outcomes and Prognostic Factors of Spontaneously Ruptured Hepatocellular Carcinoma pp.1873-4626, 2018,
  5. Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas vol.30, pp.7, 2018,